Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010

被引:3499
|
作者
Newman, David J. [1 ]
Cragg, Gordon M. [1 ]
机构
[1] NCI, Nat Prod Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21702 USA
来源
JOURNAL OF NATURAL PRODUCTS | 2012年 / 75卷 / 03期
关键词
DIVERSITY-ORIENTED SYNTHESIS; CHROMOBACTERIUM-VIOLACEUM NO-968; AT(2) RECEPTOR; BIOLOGICAL-PROPERTIES; MULTIPLE-SCLEROSIS; ANTITUMOR-ACTIVITY; FINGOLIMOD FTY720; CHEMICAL SPACE; SHIKIMIC ACID; MARKET;
D O I
10.1021/np200906s
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
This review is an updated and expanded version of the three prior reviews that were published in this journal in 1997, 2003, and 2007. In the case of all approved therapeutic agents, the time frame has been extended to cover the 30 years from January 1, 1981, to December 31, 2010, for all diseases worldwide, and from 1950 (earliest so far identified) to December 2010 for all approved antitumor drugs worldwide. We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions and have added a new designation, "natural product botanical" or "NB", to cover those botanical "defined mixtures" that have now been recognized as drug entities by the FDA and similar organizations. From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well. Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 175 small molecules, 131, or 74.8%, are other than "S" (synthetic), with 85, or 48.6%, actually being either natural products or directly derived therefrom. In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures. Although combinatorial chemistry techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compound approved as a drug in this 30-year time frame. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.
引用
收藏
页码:311 / 335
页数:25
相关论文
共 9 条
  • [1] Natural Products as Sources of New Drugs from 1981 to 2014
    Newman, David J.
    Cragg, Gordon M.
    JOURNAL OF NATURAL PRODUCTS, 2016, 79 (03): : 629 - 661
  • [2] Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
    Newman, David J.
    Cragg, Gordon M.
    JOURNAL OF NATURAL PRODUCTS, 2020, 83 (03): : 770 - 803
  • [3] Reptiles as Promising Sources of Medicinal Natural Products for Cancer Therapeutic Drugs
    Park, Soon Yong
    Choi, Hyeongrok
    Chung, Jin Woong
    PHARMACEUTICS, 2022, 14 (04)
  • [4] An enumeration of natural products from microbial, marine and terrestrial sources
    Ntie-Kang, Fidele
    Svozil, Daniel
    PHYSICAL SCIENCES REVIEWS, 2020, 5 (08)
  • [5] Computational Approaches to Enzyme Inhibition by Marine Natural Products in the Search for New Drugs
    Gago, Federico
    MARINE DRUGS, 2023, 21 (02)
  • [6] CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy
    Huang, Jiawen
    Yang, Qian
    Wang, Wen
    Huang, Juan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [7] New Method for the Rapid Extraction of Natural Products: Efficient Isolation of Shikimic Acid from Star Anise
    Just, Jeremy
    Deans, Bianca J.
    Olivier, Wesley J.
    Paull, Brett
    Bissember, Alex C.
    Smith, Jason A.
    ORGANIC LETTERS, 2015, 17 (10) : 2428 - 2430
  • [8] New and Highly Potent Antitumor Natural Products from Marine-Derived Fungi: Covering the Period from 2003 to 2012
    Pejin, Boris
    Jovanovic, Katarina K.
    Mojovic, Milo
    Savic, Aleksandar G.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (21) : 2745 - 2766
  • [9] Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs
    Egieyeh, Samuel Ayodele
    Syce, James
    Malan, Sarel F.
    Christoffels, Alan
    MALARIA JOURNAL, 2016, 15